Gardasil Lawsuit Attorneys

We have an updated case count in the Gardasil MDL. As of today, 143 claims are pending in the Gardasil Products Liability Litigation before Judge Kenneth D. Bell in North Carolina. Our vaccine attorneys have several cases making their way through Vaccine Court, so we anticipate this number to increase steadily in the next few months.

Last month, our attorneys filed two new Gardasil death cases on behalf of two mothers who allege the HPV vaccine caused severe autoimmune and neurological dysfunction, ultimately resulting in the deaths of their daughters.

January is cervical cancer awareness month, which means HPV vaccination will be broadcast as a “primary prevention” mechanism against cervical cancer. As attorneys litigating cases for those harmed by the Gardasil vaccine, we wanted to take a moment to provide some important information on the HPV vaccine and cervical cancer.

Merck has previously marketed Gardasil as a “cervical cancer vaccine” and asserted that Gardasil provides lifetime immunity to cervical, anal, and other HPV-associated cancers. Our lawsuits allege Merck does not have any scientifically reliable basis to make these claims. The question of whether the HPV vaccine prevents cancer is unproven, and evidence exists that Gardasil may actually increase the risk of cervical cancer in those previously exposed to HPV rather than prevent it.

We filed a case last year on behalf of a young woman who alleges Gardasil caused her cervical cancer. “Because most of her treatment was directed at her cervix,” the complaint states, “her ovaries were also affected, putting her into menopause in her 20s…She will never be able to have children of her own because her eggs are no longer viable due to the cancer treatment.”

Our complaint accuses Merck of falsely advertising and overstating Gardasil’s safety and effectiveness, which not only failed to prevent our client’s cervical cancer, it potentially caused her to develop cancer.

Raising awareness about cervical cancer is important. But the public deserves to be fully informed about the potential for harm that comes with HPV vaccination.

The federal Gardasil MDL continues to grow with new cases added each month. As of today, there are 104 cases pending in the MDL. Our firm has 140 cases that have made their way through Vaccine Court and will soon be filed in the MDL, so the number of cases will increase significantly over the next few months.

As for the California Gardasil litigation, we have seven cases pending with more to be filed in the coming months.

We recently received some requests for data on the number of Gardasil claims in Vaccine Court. Since February 2007, there have been 844 Gardasil petitions filed in the VICP, including 22 for wrongful death as of October 1, 2023. More than 200 HPV vaccine claims are still pending.

As for the ongoing Gardasil MDL, there are now 110 cases consolidated in federal court. The cases considered for bellwether trials allege two serious Gardasil side effects:

Premature Ovarian Insufficiency (POI) / Premature Ovarian Failure (POF): A debilitating condition that manifests when a woman's ovaries do not function properly before the age of 40. POI / POF may result in irregular or absent menstrual periods and infertility. Numerous factors contribute to the onset of POI / POF, including genetic predispositions, the presence of autoimmune diseases, and specific medical treatments. You can read more about Gardasil and ovarian failure in our blog – Gardasil HPV Vaccine Studies.

Postural Orthostatic Tachycardia Syndrome (POTS): A condition characterized by an abnormal escalation in heart rate upon transitioning from a reclining or seated position to an upright stance. This physiological anomaly elicits distressing symptoms ranging from dizziness and lightheadedness to debilitating fatigue and, at times, episodes of fainting. You can learn more about POTS symptoms and the link between Gardasil and POTS in our blog – Can Gardasil Cause POTS?

We can also report that there are several cases filed in California state court as the litigation is starting to grow.

If you are curious to know more about the scientific research linking the HPV vaccine to autoimmune disorders like POTS, dysautonomia, CRPS, POF, and several other health issues, we recently posted a blog detailing findings from dozens of studies, as well as links to the studies themselves.

The Gardasil MDL will soon include more than 100 claims. As of the latest MDL statistics report, there are 96 active cases in the Gardasil MDL.

The federal Judge overseeing the Gardasil MDL has indicated that the litigation will be bifurcated into two phases. The first phase will address the issue of general causation (whether the HPV vaccine is capable of causing the alleged side effects). The second phase will address all remaining liability and damage issues.

Thirteen of the 16 plaintiffs selected as bellwether candidates have filed amended complaints, per the latest case management conference on August 29. Additionally, one of the cases Merck chose as a bellwether candidate was dismissed with prejudice. The company will soon select a replacement.

With nearly 100 cases in the MDL, there are currently hundreds of additional claims making their way through Vaccine Court. We believe many of these cases will enter the MDL in the coming months.

As of today, there are 92 Gardasil lawsuits pending in the MDL. In September, our firm and colleagues with cases in the MDL will start conducting depositions. A deposition is an important part of the discovery process where attorneys question experts, company representatives, and other parties under oath. In these depositions, we plan to gather testimony and facts about what Merck knew about Gardasil and its potential to cause injuries, and more.

Other upcoming events in the Gardasil MDL: Plaintiff Expert reports are due in March of 2024, and we anticipate an order on summary judgment in the fall of 2024. This order will determine the next phase of the litigation. If Judge Conrad denies Merck’s motion for summary judgment, the litigation will move toward trial.

Gardasil lawyers at Wisner Baum and colleagues in the federal MDL recently submitted a joint report to the judge overseeing the litigation. The report detailed progress as attorneys prepare the initial group of bellwether cases. Bellwether trials are essentially test cases that indicate potential results for the pool of similar lawsuits.

A total of 16 claims were selected as bellwether cases; the plaintiffs selected five cases, Merck selected five cases, four were selected at random, and U.S. District Judge Robert J. Conrad selected the remaining two. The first Gardasil trial in the federal MDL will likely occur in late 2024 or early 2025.

Although the outcomes of the bellwether trials will not be binding on other claims, they will be closely monitored to assess how juries respond to the evidence and expert testimony. The average payouts in these cases may influence settlement offers from Merck to avoid individual cases going before juries.

As of this writing, there are at least 89 cases in the Gardasil MDL, though we expect this number to increase significantly in the coming months as hundreds of claims are pending in Vaccine Court. Those who allege HPV vaccine side effects must first bring their claims to Vaccine Court before they can file a lawsuit against Merck in civil court.

Gardasil lawsuits are progressing in the federal MDL. As of this date, there are 86 cases in the Gardasil MDL, many of which were filed on behalf of our clients. We have 88 other Gardasil cases that have gone through Vaccine Court and are being worked up for filing in civil court. Over 100 cases are pending in Vaccine Court with 32 others that are being prepared to file.

While the Gardasil MDL is where federal cases are consolidated, there are Gardasil cases filed in California state court as well. As of this date, seven are pending in California.

We are pleased to report that the judge overseeing the federal Gardasil MDL in North Carolina recently ordered Merck to produce its entire database of Gardasil adverse events to attorneys representing women and men suing the company over Gardasil-induced autoimmune conditions. With the order, plaintiffs’ attorneys and their experts will have access to Merck’s adverse event database under a protective order.

U.S. District Judge Robert J. Conrad, Jr. wrote in his order, “[p]laintiffs’ and their experts should have the same opportunity as Merck to review and analyze the entirety of the data.”

“Gaining access to the entire Gardasil adverse event database enables expert scientists who have been demanding this information for years to finally research the patterns of complex autoimmune conditions, not just the sequestered view Merck had been imposing,” says Wisner Baum Gardasil lawyer, Michael L. Baum.

Learn more in our press release.

There are now approximately 65 cases currently part of the Gardasil MDL. Another 80 cases, which have already gone through the mandatory Vaccine Injury Compensation Program, are expected to be filed in the MDL in the coming year.

At least 115 cases are currently pending in the Vaccine Injury Compensation Program (VICP), the majority of which are expected to end up in the MDL. Another 150 cases are under review, and new cases are coming in and being evaluated every day.

Additionally, there are seven Gardasil cases pending in various California state courts.

The federal judge who oversees the federal Gardasil multidistrict litigation (or Gardasil MDL) has appointed Wisner Baum senior shareholder Bijan Esfandiari to serve as co-lead counsel for the plaintiffs. Esfandiari is among four attorneys who will serve on the litigation leadership for plaintiffs throughout the country who allege in lawsuits against Merck that the Gardasil HPV vaccine causes severe side effects.

The Gardasil lawyer team that will serve on the plaintiff’s leadership include:

• Bijan Esfandiari – Wisner Baum
• Rachel Lanier – The Lanier Law Firm
• Paul Pennock – Morgan & Morgan
• Allison Mullins – Turning Point Litigation (Liaison Counsel)

"We are pleased that the judge appointed an alliance of proven litigators to represent Gardasil survivors," Gardasil lawyer Bijan Esfandiari said following a status conference. "We look forward to giving our clients the chance to finally be heard in court backed by a group of lawyers with proven success in high-stakes litigation. We will work together to seek justice for people who have seen their lives destroyed by a defective and dangerous product."

Wisner Baum has filed the first Gardasil lawsuit to allege wrongful death in civil court. The firm’s attorneys filed the case on behalf of a couple from North Carolina who allege the Gardasil HPV vaccine killed their 13-year-old son. Clifton and Kelli Foley allege Merck “engaged in a relentless propaganda campaign aimed at frightening and guilting parents” who did not vaccinate their children with the HPV vaccine, and that the company refused to warn the public of the risk of serious side effects, according to the complaint. The Foley’s son, Noah, passed away at age 13 of encephalitis. The Gardasil lawsuit alleges Noah’s death stemmed from an autoimmune/autoinflammatory dysregulation process, which was caused-in-fact by the Gardasil shot received in 2018.

Watch Video: 13-Year-Old Noah Foley’s Untimely Death After Gardasil

Gardasil lawyers representing plaintiffs who suffer from serious health disorders after receiving the HPV vaccine filed a position statement today outlining the allegations they plan to pursue against Gardasil’s manufacturer, Merck & Co. Filed on behalf of plaintiffs who suffer from various injuries (most prominently, neurological, autonomic and autoimmune injuries, including Postural Orthostatic Tachycardia Syndrome or Orthostatic Intolerance), the position statement alleges Merck failed to warn consumers about Gardasil's risks of inducing certain autoimmune and neurological injuries. The position statement further alleges Merck took steps to mask and downplay these risks.

“Merck was also negligent in the way it conducted its clinical trials and post-marketing pharmacovigilance,” the position statement reads. “Plaintiffs further allege that, in its direct-to-consumer advertising to patients and parents, Merck misrepresented and overemphasized Gardasil's efficacy while concealing Gardasil's serious risks."

You can read the position statement in its entirety here: Gardasil MDL Plaintiffs Position Statement

The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order today consolidating Gardasil vaccine lawsuit claims before U.S. District Court Judge Robert J. Conrad, Jr. of the Western District of North Carolina. With the establishment of the Gardasil MDL, "In re: Gardasil Products Liability Litigation MDL No. 3036," HPV vaccine cases can move into coordinated discovery and pretrial proceedings.

"We are very pleased the JPML decided to centralize the Gardasil litigation. Efficient coordination of the multidistrict litigation makes the most sense and gives the plaintiffs the best path for seeking and obtaining justice. Our clients are looking forward to getting their day in court." – Gardasil Attorney Bijan Esfandiari

Judge Conrad has scheduled an initial conference for October 11, 2022 during which the parties and the Court will discuss “procedures that will facilitate the expeditious, economical, and just resolution of this litigation.” During the initial conference, scheduling, discovery, appointments of lead counsel and liaison counsel, a Plaintiff’s Steering Committee, and a plan for alternative dispute resolution, among other things, will be discussed.